Replicative senescence and the art of counting

Experimental Gerontology

Volumn 38, Issue 11-12, 2003, Pages 1259-1264

  Von Zglinicki, Thomas ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Fibroblast; Hayflick limit; Replicometer; Senescence; Stress; Telomeres

Indexed keywords

GALACTOSYLCERAMIDASE; PROTIRELIN DERIVATIVE; TELOMERASE REVERSE TRANSCRIPTASE;

AGING; BIOLOGICAL RHYTHM; CELL AGING; CELL COUNT; CELL CULTURE; CELL DAMAGE; CELL DIVISION; CELL REGENERATION; DNA DAMAGE; HUMAN; MOLECULAR MECHANICS; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SENESCENCE; STRESS; TELOMERE;

EID: 0346786307     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2003.09.015     Document Type: Article

References (83)

1. Adelfalk C., Lorenz M., Serra V., von Zglinicki T., Hirsch-Kauffmann M., Schweiger M. Accelerated telomere shortening in Fanconi anemia fibroblasts - a longitudinal study. FEBS Lett. 506:2001;22-26.
2. Atamna H., Robinson C., Ingersoll R., Elliott H., Ames B.N. N-t-Butyl hydroxylamine is an antioxidant that reverses age-related changes in mitochondria in vivo and in vitro. FASEB J. 15:2001;2196-2204.
3. Baird D.M., Rowson J., Wynford-Thomas D., Kipling D. Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat. Genet. 33:2003;203-207.
4. Balin A.K., Goodman D.B., Rasmussen H., Cristofalo V.J. The effect of oxygen and vitamin E on the lifespan of human diploid cells in vitro. J. Cell. Biol. 74:1977;58-67.
5. Blackburn E.H. Telomere states and cell fates. Nature. 408:2000;53-56.
6. Blasco M.A. Immunosenescence phenotypes in the telomerase knockout mouse. Springer Semin. Immunopathol. 24:2002;75-85.
7. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
8. Boukamp P. Biological clocks in the ageing cell. von Zglinicki T. Aging at the Molecular Level. 2003;Kluwer Academic Press, Dordrecht.
9. Brod S.A. Unregulated inflammation shortens human functional longevity. Inflamm. Res. 49:2000;561-570.
10. Campisi J. From cells to organisms: what can we learn about aging from cells in culture? Exp. Gerontol. 36:2001;607-618.
11. Campisi J. Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp. Gerontol. 38:2003;5-12.
12. Cawthon R.M., Smith K.R., O'Brien E., Sivatchenko A., Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 361:2003;393-395.
13. Chen Q.M., Ames B.N. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl Acad. Sci. USA. 91:1994;4130-4134.
14. Chen Q.M., Fischer A., Reagan J.D., Yan L.J., Ames B.N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl Acad. Sci. USA. 92:1995;4337-4341.
15. Chen Q.M., Prowse K.R., Tu V.C., Purdom S., Linskens M.H. Uncoupling the senescent phenotype from telomere shortening in hydrogen peroxide-treated fibroblasts. Exp. Cell Res. 265:2001;294-303.
16. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., Greider C.W., DePinho R.A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 97:1999;527-538.
17. Clark A.J., Ferrier P., Aslam S., Burl S., Denning C., Wylie D., Ross A., De Sousa P., Wilmut I., Cui W. Proliferative lifespan is conserved after nuclear transfer. Nat. Cell Biol. 5:2003;535-538.
18. Dierick J.F., Kalume D.E., Wenders F., Salmon M., Dieu M., Raes M., Roepstorff P., Toussaint O. Identification of 30 protein species involved in replicative senescence and stress-induced premature senescence. FEBS Lett. 531:2002;499-504.
19. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA. 92:1995;9363-9367.
20. Dimri G.P., Martinez J.L., Jacobs J.J., Keblusek P., Itahana K., Van Lohuizen M., Campisi J., Wazer D.E., Band V. The Bmi-1 oncogene induces telomerase activity and immortalises human mammary epithelial cells. Cancer Res. 62:2002;4736-4745.
21. Dumont P., Burton M., Chen Q.M., Gonos E.S., Frippiat C., Mazarati J.B., Eliaers F., Remacle J., Toussaint O. Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Radic. Biol. Med. 28:2000;361-373.
22. Faragher R.G., Kipling D. How might replicative senescence contribute to human ageing? Bioessays. 20:1998;985-991.
23. Ferbeyre G., de Stanchina E., Lin A.W., Querido E., McCurrach M.E., Hannon G.J., Lowe S.W. Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell. Biol. 22:2002;3497-3508.
24. Frippiat C., Chen Q.M., Zdanov S., Magalhaes J.P., Remacle J., Toussaint O. Subcytotoxic H2O2 stress triggers a release of transforming growth factor-beta 1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J. Biol. Chem. 276:2001;2531-2537.
25. Furumoto K., Inoue E., Nagao N., Hiyama E., Miwa N. Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress. Life Sci. 63:1998;935-948.
26. Gorbunova V., Seluanov A., Pereira-Smith O.M. Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J. Biol. Chem. 277:2002;38540-38549.
27. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., CBiachi A., Moss H., de Lange T. Mammalian telomeres end in a large duplex loop. Cell. 97:1999;503-514.
28. de Haan G., Gelman R., Watson A., Yunis E., van Zant G. A putative gene causes variability in lifespan among genotypically identical mice. Nat. Genet. 19:1998;114-116.
29. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature. 345:1990;458-460.
30. Hayflick L. The illusion of cell immortality. Br. J. Cancer. 83:2000;841-846.
31. Hayflick L., Moorehead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:1961;585-621.
32. Hemann M.T., Strong M.A., Hao L.Y., Greider C. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 107:2001;67-77.
33. Herskind C., Rodemann H.P. Spontaneous and radiation-induced differentiation of fibroblasts. Exp. Gerontol. 35:2000;747-755.
34. Huffman K.E., Levene S.D., Tesmer V.M., Shay J.W., Wright W.E. Telomere shortening is proportional to the size of the G-rich telomeric 3′-overhang. J. Biol. Chem. 275:2000;19719-19722.
35. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 283:1999;1321-1325.
36. Karlseder J., Smogorzewska A., de Lange T. Senescence induced by altered telomere state, not telomere loss. Science. 295:2002;2446-2450.
37. Kashino G., Kodama S., Nakayama Y., Suzuki K., Fukase K., Goto M., Watanabe M. Relief of oxidative stress by ascorbic acid delays cellular senescence of normal human and Werner syndrome fibroblast cells. Free Radic. Biol. Med. 35:2003;438-443.
38. Kelso G.F., Porteous C.M., Hughes G., Ledgerwood E.C., Gane A.M., Smith R.A., Murphy M.P. Prevention of mitochondrial oxidative damage using targeted antioxidants. Ann. NY Acad. Sci. 959:2002;263-274.
39. Kill I.R., Faragher R.G., Lawrence K., Shall S. The expression of proliferation-dependent antigens during the lifespan of normal and progeroid human fibroblasts in culture. J. Cell Sci. 107:1994;571-579.
40. Kirkwood T.B.L., Finch C.E. Ageing: the old worm turns more slowly. Nature. 419:2002;794-795.
41. Krtolica A., Rarrinello S., Lockett S., Desprez P.Y., Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. USA. 98:2001;12072-12077.
42. Kruk P.A., Rampino N.J., Bohr V.A. DNA damage and repair in telomeres: relation to aging. Proc. Natl Acad. Sci. USA. 92:1995;258-262.
43. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signalling. Genes Dev. 12:1998;3008-3019.
44. Makarov V.L., Hirose Y., Langmore J.P. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell. 88:1997;657-666.
45. Martens U.M., Chavez E.A., Poon S.S., Schmoor C., Lansdorp P.M. Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp. Cell Res. 256:2000;291-299.
46. Ogryzko V.V., Hirai T.H., Russanova V.R., Barbie D.A., Howard B.H. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16:1996;5210-5218.
47. Olovnikov A.M. A theory of marginotomy: the incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the problem. J. Theor. Biol. 41:1973;181-190.
48. Petersen S., Saretzki G., von Zglinicki T. Preferential accumulation of single-stranded regions in telomeres of human fibroblasts. Exp. Cell Res. 239:1998;152-160.
49. Rabinovitch P.S. Regulation of human fibroblast growth rate by both non-cycling cell fraction and transition probability is shown by growth in 5-bromodeoxyuridine followed by Hoechst 33258 flow cytometry. Proc. Natl Acad. Sci. USA. 80:1983;2951-2955.
50. Robles S.J., Adami G.R. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene. 16:1998;1113-1123.
51. Rouse J., Jackson S.P. Interfaces between the detection, signaling, and repair of DNA damage. Science. 297:2002;547-551.
52. Rubin H. The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat. Biotechnol. 20:2002;675-681.
53. Samani N.J., Boultby R., Butler R., Thompson J.R., Goodall A.H. Telomere shortening in atherosclerosis. Lancet. 358:2001;472-473.
54. Saretzki G., Feng J., von Zglinicki T., Villeponteau B. Similar gene expression pattern in senescent and hyperoxic-treated fibroblasts. J. Gerontol. 53A:1998;B438-B442.
55. Saretzki G., Sitte N., Merkel U., Wurm R.E., von Zglinicki T. Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments. Oncogene. 18:1999;5148-5158.
56. Saretzki G., Murphy M.P., von Zglinicki T. MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress. Ageing Cell. 2:2003;141-143.
57. Serra V., von Zglinicki T. Human fibroblasts in vitro senesce with a donor-specific telomere length. FEBS Lett. 516:2002;71-74.
58. Serra V., Grune T., Sitte N., Saretzki G., von Zglinicki T. Telomere length as a marker of oxidative stress in primary human fibroblast cultures. Ann. NY Acad. Sci. 908:2000;327-330.
59. Serra V., von Zglinicki T., Lorenz M., Saretzki G. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows down telomere shortening. J. Biol. Chem. 278:2003;6824-6830.
60. Shelton D.N., Chang E., Whittier P.S., Choi D., Funk W.D. Microarray analysis of replicative senescence. Curr. Biol. 9:1999;939-945.
61. Sherr C.J., DePinho R.A. Cellular senescence: mitotic clock or culture shock? Cell. 102:2000;407-410.
62. Sitte N., Saretzki G., von Zglinicki T. Accelerated telomere shortening in fibroblasts after extended periods of confluency. Free Radic. Biol. Med. 24:1998;885-893.
63. Sitte N., Merker K., Von Zglinicki T., Davies K.J., Grune T. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II - aging of nondividing cells. FASEB J. 14:2000;2503-2510.
64. Sitte N., Merker K., Grune T., von Zglinicki T. Lipofuscin accumulation in proliferating fibroblasts in vitro: an indicator of oxidative stress. Exp. Gerontol. 36:2001;475-486.
65. Smith J.R., Whitney R.G. Intraclonal variation in proliferative potential of human diploid fibroblasts: stochastic mechanism for cellular aging. Science. 207:1980;82-84.
66. Smogorzewska A., De Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21:2002;4338-4348.
67. Stampfer M.R., Yaswen P. Human epithelial cell immortalisation as a step in carcinogenesis. Cancer Lett. 194:2003;199-208.
68. Stewart S.A., Ben-Porath I., Carey V.J., O'Connor B.F., Hahn W.C., Weinberg R.A. Erosion of the telomere single-strand overhang at replicative senescence. Nat. Genet. 33:2003;492-496.
69. Thomas E., Al-Baker E., Dropcova S., Denyer S., Ostad N., Lloyd A.C., Kill I.R., Faragher R.G. Different kinetics of senescence in human fibroblasts and peritoneal mesothelial cells. Exp. Cell Res. 236:1997;355-358.
70. Toussaint O., Medrano E.E., von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp. Gerontol. 35:2000;927-945.
71. Watson J.D. Origin of concatemeric DNA. Nat. New Biol. 239:1972;197-201.
72. Webley K., Bond J.A., Jones C.J., Blaydes J.P., Craig A., Hupp T., Wynford-Thomas D. Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol. Cell. Biol. 20:2000;2803-2808.
73. Wright W.E., Shay J.W. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet. Dev. 11:2001;98-103.
74. Wright W.E., Shay J.W. Historical claims and current interpretations of replicative aging. Nat. Biotechnol. 20:2002;682-688.
75. Xie S., Wang Q., Wu H., Cogswell J., Lu L., Jhanwar-Uniyal M., Dai W. Reactive oxygen species induced-phosphorylation of p53 on serine-20 is mediated in part by Plk3. J. Biol. Chem. 276:2001;36194-36199.
76. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann. NY Acad. Sci. 908:2000;99-110.
77. von Zglinicki T. Telomeres and replicative senescence: is it only length that counts? Cancer Lett. 168:2001;111-116.
78. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 27:2002;339-344.
79. von Zglinicki T., Saretzki G., Docke W., Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp. Cell Res. 220:1995;186-193.
80. von Zglinicki T., Pilger R., Sitte N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic. Biol. Med. 28:2000;64-74.
81. von Zglinicki T., Serra V., Lorenz M., Saretzki G., Lenzen- Grossimlighaus R., Gessner R., Risch A., Steinhagen-Thiessen E. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab. Invest. 80:2000;1739-1747.
82. von Zglinicki T., Buerkle A., Kirkwood T.B.L. Stress, DNA damage and ageing - an integrative apporach. Exp. Gerontol. 36:2001;1049-1062.
83. von Zglinicki T., Petrie J., Kirkwood T.B.L. Replicative senescence is a stress response. Nat. Biotechnol. 21:2003;229-230.